Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Assets (2016 - 2025)

Iovance Biotherapeutics has reported Return on Assets over the past 9 years, most recently at 0.43% for Q4 2025.

  • Quarterly results put Return on Assets at 0.43% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 0.43% (changed N/A YoY), and the annual figure for FY2025 was 0.43%, up 1.0%.
  • Return on Assets for Q4 2025 was 0.43% at Iovance Biotherapeutics, up from 0.44% in the prior quarter.
  • Over the last five years, Return on Assets for IOVA hit a ceiling of 0.39% in Q2 2023 and a floor of 0.54% in Q1 2024.
  • Median Return on Assets over the past 3 years was 0.43% (2025), compared with a mean of 0.45%.
  • Biggest five-year swings in Return on Assets: decreased -15bps in 2024 and later increased 14bps in 2025.
  • Iovance Biotherapeutics' Return on Assets stood at 0.54% in 2023, then fell by 0bps to 0.54% in 2024, then grew by 21bps to 0.43% in 2025.
  • The last three reported values for Return on Assets were 0.43% (Q4 2025), 0.44% (Q3 2025), and 0.42% (Q2 2025) per Business Quant data.